| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| ILMN - Illumina Inc | BUY | 1,470 @ USD 150.14 | USD 220,706 | The ETF bought 1470 new shares of ILMN (Illumina Inc). The shares were bought for an average price of 150.14 compared to the previous average buy price of 96.7199. This is 55.2% higher than average price of previous purchases of ILMN. |
| UCB.BR - UCB SA | BUY | 688 @ EUR 299.368 | EUR 205,965 | The ETF bought 688 new shares of UCB.BR (UCB SA). The shares were bought for an average price of 299.368 compared to the previous average buy price of 215.651. This is 38.8% higher than average price of previous purchases of UCB.BR. |
| EXAS - EXACT Sciences Corporation | BUY | 1,984 @ USD 101.63 | USD 201,634 | The ETF bought 1984 new shares of EXAS (EXACT Sciences Corporation). The shares were bought for an average price of 101.63 compared to the previous average buy price of 66.1767. This is 53.6% higher than average price of previous purchases of EXAS. |
| NTRA - Natera Inc | BUY | 784 @ USD 254.4 | USD 199,450 | The ETF bought 784 new shares of NTRA (Natera Inc). The shares were bought for an average price of 254.4 compared to the previous average buy price of 181.943. This is 39.8% higher than average price of previous purchases of NTRA. |
| IQV - IQVIA Holdings Inc | BUY | 810 @ USD 244.29 | USD 197,875 | The ETF bought 810 new shares of IQV (IQVIA Holdings Inc). The shares were bought for an average price of 244.29 compared to the previous average buy price of 164.563. This is 48.4% higher than average price of previous purchases of IQV. |
| TMO - Time Out Group plc | BUY | 312 @ USD 617.15 | USD 192,551 | The ETF bought 312 new shares of TMO (Time Out Group plc). The shares were bought for an average price of 617.15 compared to the previous average buy price of 423.975. This is 45.6% higher than average price of previous purchases of TMO. |
| GMAB.CO - | BUY | 564 @ DKK 338.853 | DKK 191,113 | The ETF bought 564 new shares of GMAB.CO (). The shares were bought for an average price of 338.853 compared to the previous average buy price of 226.549. This is 49.6% higher than average price of previous purchases of GMAB.CO. |
| BIIB - Biogen Inc | BUY | 954 @ USD 186.91 | USD 178,312 | The ETF bought 954 new shares of BIIB (Biogen Inc). The shares were bought for an average price of 186.91 compared to the previous average buy price of 131.648. This is 42.0% higher than average price of previous purchases of BIIB. |
| MRK - Marks Electrical Group PLC | BUY | 1,590 @ USD 108.6 | USD 172,674 | The ETF bought 1590 new shares of MRK (Marks Electrical Group PLC). The shares were bought for an average price of 108.6 compared to the previous average buy price of 81.474. This is 33.3% higher than average price of previous purchases of MRK. |
| MRK - Merck & Company Inc | BUY | 1,590 @ USD 108.6 | USD 172,674 | The ETF bought 1590 new shares of MRK (Merck & Company Inc). The shares were bought for an average price of 108.6 compared to the previous average buy price of 81.474. This is 33.3% higher than average price of previous purchases of MRK. |
| JNJ - Johnson & Johnson | BUY | 826 @ USD 207.49 | USD 171,387 | The ETF bought 826 new shares of JNJ (Johnson & Johnson). The shares were bought for an average price of 207.49 compared to the previous average buy price of 176.223. This is 17.7% higher than average price of previous purchases of JNJ. |
| GSK.L - GlaxoSmithKline PLC | BUY | 6,348 @ GBP 25.6313 | GBP 162,707 | The ETF bought 6348 new shares of GSK.L (GlaxoSmithKline PLC). The shares were bought for an average price of 25.6313 compared to the previous average buy price of 19.8054. This is 29.4% higher than average price of previous purchases of GSK.L. |
| ROG.SW - | BUY | 378 @ CHF 424.474 | CHF 160,451 | The ETF bought 378 new shares of ROG.SW (). The shares were bought for an average price of 424.474 compared to the previous average buy price of 334.632. This is 26.8% higher than average price of previous purchases of ROG.SW. |
| ABBV - AbbVie Inc | BUY | 682 @ USD 233.42 | USD 159,192 | The ETF bought 682 new shares of ABBV (AbbVie Inc). The shares were bought for an average price of 233.42 compared to the previous average buy price of 204.991. This is 13.9% higher than average price of previous purchases of ABBV. |
| A - Agilent Technologies Inc | BUY | 1,074 @ USD 147.81 | USD 158,748 | The ETF bought 1074 new shares of A (Agilent Technologies Inc). The shares were bought for an average price of 147.81 compared to the previous average buy price of 123.184. This is 20.0% higher than average price of previous purchases of A. |
| 068270.KS - CELLTRION INC | BUY | 1,088 @ KRW 145.895 | KRW 158,734 | The ETF bought 1088 new shares of 068270.KS (CELLTRION INC). The shares were bought for an average price of 145.895 compared to the previous average buy price of 122.306. This is 19.3% higher than average price of previous purchases of 068270.KS. |
| NOVN.SW - | BUY | 1,090 @ CHF 142.579 | CHF 155,411 | The ETF bought 1090 new shares of NOVN.SW (). The shares were bought for an average price of 142.579 compared to the previous average buy price of 116.613. This is 22.3% higher than average price of previous purchases of NOVN.SW. |
| MEDP - Medpace Holdings Inc | BUY | 252 @ USD 613.09 | USD 154,499 | The ETF bought 252 new shares of MEDP (Medpace Holdings Inc). The shares were bought for an average price of 613.09 compared to the previous average buy price of 400.922. This is 52.9% higher than average price of previous purchases of MEDP. |
| AMGN - Amgen Inc | BUY | 440 @ USD 341.64 | USD 150,322 | The ETF bought 440 new shares of AMGN (Amgen Inc). The shares were bought for an average price of 341.64 compared to the previous average buy price of 299.092. This is 14.2% higher than average price of previous purchases of AMGN. |
| DHR - Danaher Corporation | BUY | 638 @ USD 235.57 | USD 150,294 | The ETF bought 638 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 235.57 compared to the previous average buy price of 201.106. This is 17.1% higher than average price of previous purchases of DHR. |
| DHR - Danaher Corporation | BUY | 638 @ USD 235.57 | USD 150,294 | The ETF bought 638 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 235.57 compared to the previous average buy price of 201.106. This is 17.1% higher than average price of previous purchases of DHR. |
| HOLX - Hologic Inc | BUY | 1,986 @ USD 74.96 | USD 148,871 | The ETF bought 1986 new shares of HOLX (Hologic Inc). The shares were bought for an average price of 74.96 compared to the previous average buy price of 66.7263. This is 12.3% higher than average price of previous purchases of HOLX. |
| BMY - Bloomsbury Publishing Plc | BUY | 2,590 @ USD 56.72 | USD 146,905 | The ETF bought 2590 new shares of BMY (Bloomsbury Publishing Plc). The shares were bought for an average price of 56.72 compared to the previous average buy price of 53.3789. This is 6.3% higher than average price of previous purchases of BMY. |
| MDT - Medtronic PLC | BUY | 1,470 @ USD 99.77 | USD 146,662 | The ETF bought 1470 new shares of MDT (Medtronic PLC). The shares were bought for an average price of 99.77 compared to the previous average buy price of 90.9719. This is 9.7% higher than average price of previous purchases of MDT. |
| GILD - Guild Esports Plc | BUY | 1,176 @ USD 124.35 | USD 146,236 | The ETF bought 1176 new shares of GILD (Guild Esports Plc). The shares were bought for an average price of 124.35 compared to the previous average buy price of 108.874. This is 14.2% higher than average price of previous purchases of GILD. |
| MRNA - Moderna Inc | BUY | 4,070 @ USD 35.89 | USD 146,072 | The ETF bought 4070 new shares of MRNA (Moderna Inc). The shares were bought for an average price of 35.89 compared to the previous average buy price of 26.0348. This is 37.9% higher than average price of previous purchases of MRNA. |
| NBIX - Neurocrine Biosciences Inc | BUY | 1,036 @ USD 140.62 | USD 145,682 | The ETF bought 1036 new shares of NBIX (Neurocrine Biosciences Inc). The shares were bought for an average price of 140.62 compared to the previous average buy price of 128.58. This is 9.4% higher than average price of previous purchases of NBIX. |
| EW - Edwards Lifesciences Corp | BUY | 1,708 @ USD 84.83 | USD 144,890 | The ETF bought 1708 new shares of EW (Edwards Lifesciences Corp). The shares were bought for an average price of 84.83 compared to the previous average buy price of 75.1337. This is 12.9% higher than average price of previous purchases of EW. |
| ISRG - Intuitive Surgical Inc | BUY | 244 @ USD 592.27 | USD 144,514 | The ETF bought 244 new shares of ISRG (Intuitive Surgical Inc). The shares were bought for an average price of 592.27 compared to the previous average buy price of 539.322. This is 9.8% higher than average price of previous purchases of ISRG. |
| GH - Guardant Health Inc | BUY | 1,304 @ USD 109.93 | USD 143,349 | The ETF bought 1304 new shares of GH (Guardant Health Inc). The shares were bought for an average price of 109.93 compared to the previous average buy price of 60.3035. This is 82.3% higher than average price of previous purchases of GH. |
| PFE - Pfizer Inc | BUY | 5,328 @ USD 25.28 | USD 134,692 | The ETF bought 5328 new shares of PFE (Pfizer Inc). The shares were bought for an average price of 25.28 compared to the previous average buy price of 24.3851. This is 3.7% higher than average price of previous purchases of PFE. |
| 207940.KS - SAMSUNG BIOLOGICS LTD | BUY | 110 @ KRW 1221.78 | KRW 134,396 | The ETF bought 110 new shares of 207940.KS (SAMSUNG BIOLOGICS LTD). The shares were bought for an average price of 1221.78 compared to the previous average buy price of 800.215. This is 52.7% higher than average price of previous purchases of 207940.KS. |
| EXEL - Exelixis Inc | BUY | 2,870 @ USD 46.19 | USD 132,565 | The ETF bought 2870 new shares of EXEL (Exelixis Inc). The shares were bought for an average price of 46.19 compared to the previous average buy price of 38.8638. This is 18.9% higher than average price of previous purchases of EXEL. |
| PODD - Insulet Corporation | BUY | 434 @ USD 299.17 | USD 129,840 | The ETF bought 434 new shares of PODD (Insulet Corporation). The shares were bought for an average price of 299.17 compared to the previous average buy price of 283.102. This is 5.7% higher than average price of previous purchases of PODD. |
| BSX - Boston Scientific Corporation | BUY | 1,302 @ USD 98.65 | USD 128,442 | The ETF bought 1302 new shares of BSX (Boston Scientific Corporation). The shares were bought for an average price of 98.65 compared to the previous average buy price of 97.348. This is 1.3% higher than average price of previous purchases of BSX. |
| BSX - MULSTRXSSXIMETFP | BUY | 1,302 @ USD 98.65 | USD 128,442 | The ETF bought 1302 new shares of BSX (MULSTRXSSXIMETFP). The shares were bought for an average price of 98.65 compared to the previous average buy price of 97.348. This is 1.3% higher than average price of previous purchases of BSX. |
| RVTY - Revvity Inc. | BUY | 1,240 @ USD 102.99 | USD 127,708 | The ETF bought 1240 new shares of RVTY (Revvity Inc.). The shares were bought for an average price of 102.99 compared to the previous average buy price of 99.3535. This is 3.7% higher than average price of previous purchases of RVTY. |
| LONN.SW - | BUY | 184 @ CHF 689.802 | CHF 126,924 | The ETF bought 184 new shares of LONN.SW (). The shares were bought for an average price of 689.802 compared to the previous average buy price of 644.768. This is 7.0% higher than average price of previous purchases of LONN.SW. |
| ABT - Abbott Laboratories | BUY | 964 @ USD 127.04 | USD 122,467 | The ETF bought 964 new shares of ABT (Abbott Laboratories). The shares were bought for an average price of 127.04 compared to the previous average buy price of 124.68. This is 1.9% higher than average price of previous purchases of ABT. |
| CRL - Creightons Plc | BUY | 516 @ USD 216.77 | USD 111,853 | The ETF bought 516 new shares of CRL (Creightons Plc). The shares were bought for an average price of 216.77 compared to the previous average buy price of 170.17. This is 27.4% higher than average price of previous purchases of CRL. |
| TECH - Bio-Techne Corp | BUY | 1,650 @ USD 65.05 | USD 107,333 | The ETF bought 1650 new shares of TECH (Bio-Techne Corp). The shares were bought for an average price of 65.05 compared to the previous average buy price of 59.3335. This is 9.6% higher than average price of previous purchases of TECH. |
| DXCM - DexCom Inc | BUY | 1,526 @ USD 70.1 | USD 106,973 | The ETF bought 1526 new shares of DXCM (DexCom Inc). The shares were bought for an average price of 70.1 compared to the previous average buy price of 78.4278. This is -10.6% lower than average price of previous purchases of DXCM. |
| HALO - Halozyme Therapeutics Inc | BUY | 1,296 @ USD 75.11 | USD 97,343 | The ETF bought 1296 new shares of HALO (Halozyme Therapeutics Inc). The shares were bought for an average price of 75.11 compared to the previous average buy price of 61.4979. This is 22.1% higher than average price of previous purchases of HALO. |
| RGEN - Repligen Corporation | BUY | 552 @ USD 169.05 | USD 93,316 | The ETF bought 552 new shares of RGEN (Repligen Corporation). The shares were bought for an average price of 169.05 compared to the previous average buy price of 148.012. This is 14.2% higher than average price of previous purchases of RGEN. |
| 4523.T - Eisai Co., Ltd. | BUY | 3,000 @ JPY 30.1232 | JPY 90,370 | The ETF bought 3000 new shares of 4523.T (Eisai Co., Ltd.). The shares were bought for an average price of 30.1232 compared to the previous average buy price of 28.5706. This is 5.4% higher than average price of previous purchases of 4523.T. |
| PME.AX - | BUY | 592 @ AUD 144.641 | AUD 85,627 | The ETF bought 592 new shares of PME.AX (). The shares were bought for an average price of 144.641 compared to the previous average buy price of 163.513. This is -11.5% lower than average price of previous purchases of PME.AX. |
| SRT3.DE - Sartorius AG | BUY | 266 @ EUR 309.772 | EUR 82,399 | The ETF bought 266 new shares of SRT3.DE (Sartorius AG). The shares were bought for an average price of 309.772 compared to the previous average buy price of 253.196. This is 22.3% higher than average price of previous purchases of SRT3.DE. |
| 7701.T - Shimadzu Corporation | BUY | 3,000 @ JPY 27.0853 | JPY 81,256 | The ETF bought 3000 new shares of 7701.T (Shimadzu Corporation). The shares were bought for an average price of 27.0853 compared to the previous average buy price of 26.482. This is 2.3% higher than average price of previous purchases of 7701.T. |
| BIO - Bio-Rad Laboratories Inc | BUY | 222 @ USD 324.09 | USD 71,948 | The ETF bought 222 new shares of BIO (Bio-Rad Laboratories Inc). The shares were bought for an average price of 324.09 compared to the previous average buy price of 290.943. This is 11.4% higher than average price of previous purchases of BIO. |
| BIO - Biotest Aktiengesellschaft | BUY | 222 @ USD 324.09 | USD 71,948 | The ETF bought 222 new shares of BIO (Biotest Aktiengesellschaft). The shares were bought for an average price of 324.09 compared to the previous average buy price of 290.943. This is 11.4% higher than average price of previous purchases of BIO. |
| AXSM - Axsome Therapeutics Inc | BUY | 404 @ USD 170.69 | USD 68,959 | The ETF bought 404 new shares of AXSM (Axsome Therapeutics Inc). The shares were bought for an average price of 170.69 compared to the previous average buy price of 124.635. This is 37.0% higher than average price of previous purchases of AXSM. |
| BIM.PA - BioMerieux | BUY | 514 @ EUR 132.676 | EUR 68,195 | The ETF bought 514 new shares of BIM.PA (BioMerieux). The shares were bought for an average price of 132.676 compared to the previous average buy price of 122.646. This is 8.2% higher than average price of previous purchases of BIM.PA. |
| PTCT - PTC Therapeutics Inc | BUY | 834 @ USD 77.24 | USD 64,418 | The ETF bought 834 new shares of PTCT (PTC Therapeutics Inc). The shares were bought for an average price of 77.24 compared to the previous average buy price of 59.2985. This is 30.3% higher than average price of previous purchases of PTCT. |
| PRAX - Praxis Precision Medicines Inc | BUY | 216 @ USD 292.63 | USD 63,208 | The ETF bought 216 new shares of PRAX (Praxis Precision Medicines Inc). The shares were bought for an average price of 292.63 compared to the previous average buy price of 204.552. This is 43.1% higher than average price of previous purchases of PRAX. |
| RYTM - Rhythm Pharmaceuticals Inc | BUY | 610 @ USD 101.59 | USD 61,970 | The ETF bought 610 new shares of RYTM (Rhythm Pharmaceuticals Inc). The shares were bought for an average price of 101.59 compared to the previous average buy price of 71.9834. This is 41.1% higher than average price of previous purchases of RYTM. |
| 298380.KQ - ABL Bio Inc. | BUY | 376 @ KRW 145.549 | KRW 54,726 | The ETF bought 376 new shares of 298380.KQ (ABL Bio Inc.). The shares were bought for an average price of 145.549 compared to the previous average buy price of 100.334. This is 45.1% higher than average price of previous purchases of 298380.KQ. |
| 6869.T - Sysmex Corporation | BUY | 5,400 @ JPY 10.0964 | JPY 54,521 | The ETF bought 5400 new shares of 6869.T (Sysmex Corporation). The shares were bought for an average price of 10.0964 compared to the previous average buy price of 14.7177. This is -31.4% lower than average price of previous purchases of 6869.T. |
| MMS - LYXETFETUSITETFP | BUY | 594 @ USD 91.76 | USD 54,505 | The ETF bought 594 new shares of MMS (LYXETFETUSITETFP). The shares were bought for an average price of 91.76 compared to the previous average buy price of 77.1172. This is 19.0% higher than average price of previous purchases of MMS. |
| IPN.PA - Ipsen SA | BUY | 382 @ EUR 142.261 | EUR 54,344 | The ETF bought 382 new shares of IPN.PA (Ipsen SA). The shares were bought for an average price of 142.261 compared to the previous average buy price of 123.827. This is 14.9% higher than average price of previous purchases of IPN.PA. |
| ALKS - Alkermes Plc | BUY | 1,746 @ USD 29.36 | USD 51,263 | The ETF bought 1746 new shares of ALKS (Alkermes Plc). The shares were bought for an average price of 29.36 compared to the previous average buy price of 30.1849. This is -2.7% lower than average price of previous purchases of ALKS. |
| 7747.T - Asahi Intecc Co., Ltd. | BUY | 2,600 @ JPY 19.3631 | JPY 50,344 | The ETF bought 2600 new shares of 7747.T (Asahi Intecc Co., Ltd.). The shares were bought for an average price of 19.3631 compared to the previous average buy price of 16.9935. This is 13.9% higher than average price of previous purchases of 7747.T. |
| LNTH - Lantheus Holdings Inc | BUY | 724 @ USD 69.37 | USD 50,224 | The ETF bought 724 new shares of LNTH (Lantheus Holdings Inc). The shares were bought for an average price of 69.37 compared to the previous average buy price of 76.5173. This is -9.3% lower than average price of previous purchases of LNTH. |
| TGTX - TG Therapeutics Inc | BUY | 1,522 @ USD 30.34 | USD 46,177 | The ETF bought 1522 new shares of TGTX (TG Therapeutics Inc). The shares were bought for an average price of 30.34 compared to the previous average buy price of 33.1054. This is -8.4% lower than average price of previous purchases of TGTX. |
| SFZN.SW - | BUY | 416 @ CHF 99.1528 | CHF 41,248 | The ETF bought 416 new shares of SFZN.SW (). The shares were bought for an average price of 99.1528 compared to the previous average buy price of 123.442. This is -19.7% lower than average price of previous purchases of SFZN.SW. |
| SECT-B.ST - | BUY | 1,536 @ SEK 26.341 | SEK 40,460 | The ETF bought 1536 new shares of SECT-B.ST (). The shares were bought for an average price of 26.341 compared to the previous average buy price of 27.9755. This is -5.8% lower than average price of previous purchases of SECT-B.ST. |
| LGND - Ligand Pharmaceuticals Incorporated | BUY | 202 @ USD 199.96 | USD 40,392 | The ETF bought 202 new shares of LGND (Ligand Pharmaceuticals Incorporated). The shares were bought for an average price of 199.96 compared to the previous average buy price of 127.891. This is 56.4% higher than average price of previous purchases of LGND. |
| LIVN - LivaNova PLC | BUY | 574 @ USD 64.62 | USD 37,092 | The ETF bought 574 new shares of LIVN (LivaNova PLC). The shares were bought for an average price of 64.62 compared to the previous average buy price of 51.0298. This is 26.6% higher than average price of previous purchases of LIVN. |
| ACAD - ACADIA Pharmaceuticals Inc | BUY | 1,300 @ USD 27.42 | USD 35,646 | The ETF bought 1300 new shares of ACAD (ACADIA Pharmaceuticals Inc). The shares were bought for an average price of 27.42 compared to the previous average buy price of 20.3943. This is 34.4% higher than average price of previous purchases of ACAD. |
| IDYA - Ideaya Biosciences Inc | BUY | 922 @ USD 37.86 | USD 34,907 | The ETF bought 922 new shares of IDYA (Ideaya Biosciences Inc). The shares were bought for an average price of 37.86 compared to the previous average buy price of 24.0067. This is 57.7% higher than average price of previous purchases of IDYA. |
| VCYT - Veracyte Inc | BUY | 768 @ USD 45.11 | USD 34,644 | The ETF bought 768 new shares of VCYT (Veracyte Inc). The shares were bought for an average price of 45.11 compared to the previous average buy price of 34.8676. This is 29.4% higher than average price of previous purchases of VCYT. |
| BEAM - Beam Therapeutics Inc | BUY | 1,066 @ USD 28.93 | USD 30,839 | The ETF bought 1066 new shares of BEAM (Beam Therapeutics Inc). The shares were bought for an average price of 28.93 compared to the previous average buy price of 18.7837. This is 54.0% higher than average price of previous purchases of BEAM. |
| SUPN - Supernus Pharmaceuticals Inc | BUY | 596 @ USD 51.24 | USD 30,539 | The ETF bought 596 new shares of SUPN (Supernus Pharmaceuticals Inc). The shares were bought for an average price of 51.24 compared to the previous average buy price of 39.2959. This is 30.4% higher than average price of previous purchases of SUPN. |
| CPRX - Catalyst Pharmaceuticals Inc | BUY | 1,288 @ USD 22.72 | USD 29,263 | The ETF bought 1288 new shares of CPRX (Catalyst Pharmaceuticals Inc). The shares were bought for an average price of 22.72 compared to the previous average buy price of 22.4625. This is 1.1% higher than average price of previous purchases of CPRX. |
| ACLX - Arcellx Inc | BUY | 440 @ USD 65.01 | USD 28,604 | The ETF bought 440 new shares of ACLX (Arcellx Inc). The shares were bought for an average price of 65.01 compared to the previous average buy price of 64.8526. This is 0.2% higher than average price of previous purchases of ACLX. |
| CGON - CG Oncology, Inc. Common stock | BUY | 648 @ USD 42.45 | USD 27,508 | The ETF bought 648 new shares of CGON (CG Oncology, Inc. Common stock). The shares were bought for an average price of 42.45 compared to the previous average buy price of 41.5514. This is 2.2% higher than average price of previous purchases of CGON. |
| VRDN - Viridian Therapeutics Inc | BUY | 870 @ USD 30.57 | USD 26,596 | The ETF bought 870 new shares of VRDN (Viridian Therapeutics Inc). The shares were bought for an average price of 30.57 compared to the previous average buy price of 30.2047. This is 1.2% higher than average price of previous purchases of VRDN. |
| ADPT - Adaptive Biotechnologies Corp | BUY | 1,588 @ USD 16.73 | USD 26,567 | The ETF bought 1588 new shares of ADPT (Adaptive Biotechnologies Corp). The shares were bought for an average price of 16.73 compared to the previous average buy price of 7.03745. This is 137.7% higher than average price of previous purchases of ADPT. |
| BAVA.CO - | BUY | 824 @ DKK 31.2102 | DKK 25,717 | The ETF bought 824 new shares of BAVA.CO (). The shares were bought for an average price of 31.2102 compared to the previous average buy price of 25.5909. This is 22.0% higher than average price of previous purchases of BAVA.CO. |
| BANB.SW - | BUY | 334 @ CHF 76.9376 | CHF 25,697 | The ETF bought 334 new shares of BANB.SW (). The shares were bought for an average price of 76.9376 compared to the previous average buy price of 68.1823. This is 12.8% higher than average price of previous purchases of BANB.SW. |
| 326030.KS - SK BIOPHARMACEUTICALS LTD | BUY | 294 @ KRW 86.1538 | KRW 25,329 | The ETF bought 294 new shares of 326030.KS (SK BIOPHARMACEUTICALS LTD). The shares were bought for an average price of 86.1538 compared to the previous average buy price of 78.0703. This is 10.4% higher than average price of previous purchases of 326030.KS. |
| EKTA-B.ST - | BUY | 3,894 @ SEK 6.32925 | SEK 24,646 | The ETF bought 3894 new shares of EKTA-B.ST (). The shares were bought for an average price of 6.32925 compared to the previous average buy price of 5.66491. This is 11.7% higher than average price of previous purchases of EKTA-B.ST. |
| SRPT - Sarepta Therapeutics Inc | BUY | 1,050 @ USD 23.46 | USD 24,633 | The ETF bought 1050 new shares of SRPT (Sarepta Therapeutics Inc). The shares were bought for an average price of 23.46 compared to the previous average buy price of 44.2759. This is -47.0% lower than average price of previous purchases of SRPT. |
| QDEL - Quidel Corporation | BUY | 722 @ USD 33.37 | USD 24,093 | The ETF bought 722 new shares of QDEL (Quidel Corporation). The shares were bought for an average price of 33.37 compared to the previous average buy price of 29.4465. This is 13.3% higher than average price of previous purchases of QDEL. |
| TXG - 10X Genomics Inc | BUY | 1,188 @ USD 19.99 | USD 23,748 | The ETF bought 1188 new shares of TXG (10X Genomics Inc). The shares were bought for an average price of 19.99 compared to the previous average buy price of 13.4831. This is 48.3% higher than average price of previous purchases of TXG. |
| TXG - Terex Corporation | BUY | 1,188 @ USD 19.99 | USD 23,748 | The ETF bought 1188 new shares of TXG (Terex Corporation). The shares were bought for an average price of 19.99 compared to the previous average buy price of 13.4831. This is 48.3% higher than average price of previous purchases of TXG. |
| 9995.HK - REMEGEN LTD H | BUY | 2,000 @ HKD 11.7771 | HKD 23,554 | The ETF bought 2000 new shares of 9995.HK (REMEGEN LTD H). The shares were bought for an average price of 11.7771 compared to the previous average buy price of 9.68574. This is 21.6% higher than average price of previous purchases of 9995.HK. |
| DIA.MI - DiaSorin SpA | BUY | 280 @ EUR 83.9072 | EUR 23,494 | The ETF bought 280 new shares of DIA.MI (DiaSorin SpA). The shares were bought for an average price of 83.9072 compared to the previous average buy price of 61.334. This is 36.8% higher than average price of previous purchases of DIA.MI. |
| TECN.SW - | BUY | 134 @ CHF 174.208 | CHF 23,344 | The ETF bought 134 new shares of TECN.SW (). The shares were bought for an average price of 174.208 compared to the previous average buy price of 195.138. This is -10.7% lower than average price of previous purchases of TECN.SW. |
| NUVB - Nuvation Bio Inc | BUY | 2,626 @ USD 8.84 | USD 23,214 | The ETF bought 2626 new shares of NUVB (Nuvation Bio Inc). The shares were bought for an average price of 8.84 compared to the previous average buy price of 7.97749. This is 10.8% higher than average price of previous purchases of NUVB. |
| AUPH - Aurinia Pharmaceuticals Inc | BUY | 1,388 @ USD 16.02 | USD 22,236 | The ETF bought 1388 new shares of AUPH (Aurinia Pharmaceuticals Inc). The shares were bought for an average price of 16.02 compared to the previous average buy price of 11.6813. This is 37.1% higher than average price of previous purchases of AUPH. |
| CRVL - CorVel Corp | BUY | 310 @ USD 70.37 | USD 21,815 | The ETF bought 310 new shares of CRVL (CorVel Corp). The shares were bought for an average price of 70.37 compared to the previous average buy price of 111.286. This is -36.8% lower than average price of previous purchases of CRVL. |
| TWST - Twist Bioscience Corp | BUY | 590 @ USD 36.55 | USD 21,565 | The ETF bought 590 new shares of TWST (Twist Bioscience Corp). The shares were bought for an average price of 36.55 compared to the previous average buy price of 36.0684. This is 1.3% higher than average price of previous purchases of TWST. |
| ATRC - AtriCure Inc | BUY | 516 @ USD 41.77 | USD 21,553 | The ETF bought 516 new shares of ATRC (AtriCure Inc). The shares were bought for an average price of 41.77 compared to the previous average buy price of 33.6752. This is 24.0% higher than average price of previous purchases of ATRC. |
| RXRX - Recursion Pharmaceuticals Inc | BUY | 4,298 @ USD 4.86 | USD 20,888 | The ETF bought 4298 new shares of RXRX (Recursion Pharmaceuticals Inc). The shares were bought for an average price of 4.86 compared to the previous average buy price of 5.07964. This is -4.3% lower than average price of previous purchases of RXRX. |
| STOK - Stoke Therapeutics Inc | BUY | 586 @ USD 35.17 | USD 20,610 | The ETF bought 586 new shares of STOK (Stoke Therapeutics Inc). The shares were bought for an average price of 35.17 compared to the previous average buy price of 13.4707. This is 161.1% higher than average price of previous purchases of STOK. |
| 6951.T - JEOL Ltd. | BUY | 600 @ JPY 33.11 | JPY 19,866 | The ETF bought 600 new shares of 6951.T (JEOL Ltd.). The shares were bought for an average price of 33.11 compared to the previous average buy price of 33.0007. This is 0.3% higher than average price of previous purchases of 6951.T. |
| DVAX - Dynavax Technologies Corporation | BUY | 1,284 @ USD 15.41 | USD 19,786 | The ETF bought 1284 new shares of DVAX (Dynavax Technologies Corporation). The shares were bought for an average price of 15.41 compared to the previous average buy price of 13.5721. This is 13.5% higher than average price of previous purchases of DVAX. |
| HLUN-B.CO - | BUY | 2,928 @ DKK 6.72074 | DKK 19,678 | The ETF bought 2928 new shares of HLUN-B.CO (). The shares were bought for an average price of 6.72074 compared to the previous average buy price of 6.26175. This is 7.3% higher than average price of previous purchases of HLUN-B.CO. |
| CHEMM.CO - | BUY | 182 @ DKK 107.867 | DKK 19,632 | The ETF bought 182 new shares of CHEMM.CO (). The shares were bought for an average price of 107.867 compared to the previous average buy price of 79.3096. This is 36.0% higher than average price of previous purchases of CHEMM.CO. |
| KNSA - Kiniksa Pharmaceuticals Ltd | BUY | 454 @ USD 42.42 | USD 19,259 | The ETF bought 454 new shares of KNSA (Kiniksa Pharmaceuticals Ltd). The shares were bought for an average price of 42.42 compared to the previous average buy price of 40.3852. This is 5.0% higher than average price of previous purchases of KNSA. |
| RCUS - Arcus Biosciences Inc | BUY | 800 @ USD 23.2 | USD 18,560 | The ETF bought 800 new shares of RCUS (Arcus Biosciences Inc). The shares were bought for an average price of 23.2 compared to the previous average buy price of 10.304. This is 125.2% higher than average price of previous purchases of RCUS. |
| 3933.HK - THE UNITED LABORATORIES INTERNATIO | BUY | 12,000 @ HKD 1.5386 | HKD 18,463 | The ETF bought 12000 new shares of 3933.HK (THE UNITED LABORATORIES INTERNATIO). The shares were bought for an average price of 1.5386 compared to the previous average buy price of 1.66691. This is -7.7% lower than average price of previous purchases of 3933.HK. |
| HRMY - Harmony Biosciences Holdings | BUY | 480 @ USD 37.55 | USD 18,024 | The ETF bought 480 new shares of HRMY (Harmony Biosciences Holdings). The shares were bought for an average price of 37.55 compared to the previous average buy price of 33.6514. This is 11.6% higher than average price of previous purchases of HRMY. |
| BCRX - BioCryst Pharmaceuticals Inc | BUY | 2,252 @ USD 7.92 | USD 17,836 | The ETF bought 2252 new shares of BCRX (BioCryst Pharmaceuticals Inc). The shares were bought for an average price of 7.92 compared to the previous average buy price of 7.7452. This is 2.3% higher than average price of previous purchases of BCRX. |
| 13.HK - HUTCHMED (CHINA) LTD | BUY | 6,000 @ HKD 2.88455 | HKD 17,307 | The ETF bought 6000 new shares of 13.HK (HUTCHMED (CHINA) LTD). The shares were bought for an average price of 2.88455 compared to the previous average buy price of 2.99796. This is -3.8% lower than average price of previous purchases of 13.HK. |
| FTRE - Fortrea Holdings Inc. | BUY | 968 @ USD 17.49 | USD 16,930 | The ETF bought 968 new shares of FTRE (Fortrea Holdings Inc.). The shares were bought for an average price of 17.49 compared to the previous average buy price of 10.8459. This is 61.3% higher than average price of previous purchases of FTRE. |
| NEU.AX - | BUY | 1,368 @ AUD 12.2979 | AUD 16,824 | The ETF bought 1368 new shares of NEU.AX (). The shares were bought for an average price of 12.2979 compared to the previous average buy price of 8.98382. This is 36.9% higher than average price of previous purchases of NEU.AX. |
| NEOG - Neogen Corporation | BUY | 2,252 @ USD 7.38 | USD 16,620 | The ETF bought 2252 new shares of NEOG (Neogen Corporation). The shares were bought for an average price of 7.38 compared to the previous average buy price of 9.86113. This is -25.2% lower than average price of previous purchases of NEOG. |
| TNDM - Tandem Diabetes Care Inc | BUY | 718 @ USD 22.71 | USD 16,306 | The ETF bought 718 new shares of TNDM (Tandem Diabetes Care Inc). The shares were bought for an average price of 22.71 compared to the previous average buy price of 21.1819. This is 7.2% higher than average price of previous purchases of TNDM. |
| NVCR - Novocure Ltd | BUY | 1,102 @ USD 14.41 | USD 15,880 | The ETF bought 1102 new shares of NVCR (Novocure Ltd). The shares were bought for an average price of 14.41 compared to the previous average buy price of 16.2788. This is -11.5% lower than average price of previous purchases of NVCR. |
| BIOA-B.ST - | BUY | 428 @ SEK 35.8403 | SEK 15,340 | The ETF bought 428 new shares of BIOA-B.ST (). The shares were bought for an average price of 35.8403 compared to the previous average buy price of 30.1726. This is 18.8% higher than average price of previous purchases of BIOA-B.ST. |
| AXGN - Axogen Inc | BUY | 460 @ USD 32.95 | USD 15,157 | The ETF bought 460 new shares of AXGN (Axogen Inc). The shares were bought for an average price of 32.95 compared to the previous average buy price of 18.5561. This is 77.6% higher than average price of previous purchases of AXGN. |
| 4887.T - Sawai Group Holdings Co., Ltd. | BUY | 1,000 @ JPY 15.1477 | JPY 15,148 | The ETF bought 1000 new shares of 4887.T (Sawai Group Holdings Co., Ltd.). The shares were bought for an average price of 15.1477 compared to the previous average buy price of 13.3528. This is 13.4% higher than average price of previous purchases of 4887.T. |
| 2162.HK - KEYMED BIOSCIENCES INC | BUY | 2,000 @ HKD 7.50677 | HKD 15,014 | The ETF bought 2000 new shares of 2162.HK (KEYMED BIOSCIENCES INC). The shares were bought for an average price of 7.50677 compared to the previous average buy price of 5.38428. This is 39.4% higher than average price of previous purchases of 2162.HK. |
| ZYME - Zymeworks Inc. Common Stock | BUY | 536 @ USD 24.85 | USD 13,320 | The ETF bought 536 new shares of ZYME (Zymeworks Inc. Common Stock). The shares were bought for an average price of 24.85 compared to the previous average buy price of 18.5094. This is 34.3% higher than average price of previous purchases of ZYME. |
| 2252.HK - SHANGHAI MICROPORT MEDBOT CLASS H | BUY | 4,000 @ HKD 3.2981 | HKD 13,192 | The ETF bought 4000 new shares of 2252.HK (SHANGHAI MICROPORT MEDBOT CLASS H). The shares were bought for an average price of 3.2981 compared to the previous average buy price of 3.15899. This is 4.4% higher than average price of previous purchases of 2252.HK. |
| PHM.MC - Pharma Mar SA | BUY | 142 @ EUR 91.9379 | EUR 13,055 | The ETF bought 142 new shares of PHM.MC (Pharma Mar SA). The shares were bought for an average price of 91.9379 compared to the previous average buy price of 87.2276. This is 5.4% higher than average price of previous purchases of PHM.MC. |
| GLPG.AS - Galapagos NV | BUY | 396 @ EUR 32.7774 | EUR 12,980 | The ETF bought 396 new shares of GLPG.AS (Galapagos NV). The shares were bought for an average price of 32.7774 compared to the previous average buy price of 29.4493. This is 11.3% higher than average price of previous purchases of GLPG.AS. |
| DYVOX.ST - | BUY | 1,138 @ SEK 11.2968 | SEK 12,856 | The ETF bought 1138 new shares of DYVOX.ST (). The shares were bought for an average price of 11.2968 compared to the previous average buy price of 7.40257. This is 52.6% higher than average price of previous purchases of DYVOX.ST. |
| RLAY - Relay Therapeutics Inc | BUY | 1,564 @ USD 8.18 | USD 12,794 | The ETF bought 1564 new shares of RLAY (Relay Therapeutics Inc). The shares were bought for an average price of 8.18 compared to the previous average buy price of 7.0368. This is 16.2% higher than average price of previous purchases of RLAY. |
| PHARM.AS - Pharming Group NV | BUY | 7,310 @ EUR 1.72069 | EUR 12,578 | The ETF bought 7310 new shares of PHARM.AS (Pharming Group NV). The shares were bought for an average price of 1.72069 compared to the previous average buy price of 0.920936. This is 86.8% higher than average price of previous purchases of PHARM.AS. |
| BLFS - BioLife Solutions Inc | BUY | 492 @ USD 25.41 | USD 12,502 | The ETF bought 492 new shares of BLFS (BioLife Solutions Inc). The shares were bought for an average price of 25.41 compared to the previous average buy price of 25.5106. This is -0.4% lower than average price of previous purchases of BLFS. |
| CSTL - Castle Biosciences Inc | BUY | 302 @ USD 40.61 | USD 12,264 | The ETF bought 302 new shares of CSTL (Castle Biosciences Inc). The shares were bought for an average price of 40.61 compared to the previous average buy price of 21.8554. This is 85.8% higher than average price of previous purchases of CSTL. |
| SDGR - Schrodinger Inc | BUY | 648 @ USD 18.77 | USD 12,163 | The ETF bought 648 new shares of SDGR (Schrodinger Inc). The shares were bought for an average price of 18.77 compared to the previous average buy price of 20.5088. This is -8.5% lower than average price of previous purchases of SDGR. |
| 237690.KQ - ST Pharm Co.,Ltd. | BUY | 138 @ KRW 87.6059 | KRW 12,090 | The ETF bought 138 new shares of 237690.KQ (ST Pharm Co.,Ltd.). The shares were bought for an average price of 87.6059 compared to the previous average buy price of 60.6995. This is 44.3% higher than average price of previous purchases of 237690.KQ. |
| NVAX - Novavax Inc | BUY | 1,584 @ USD 7.62 | USD 12,070 | The ETF bought 1584 new shares of NVAX (Novavax Inc). The shares were bought for an average price of 7.62 compared to the previous average buy price of 6.53355. This is 16.6% higher than average price of previous purchases of NVAX. |
| NVAX - Hana Microelectronics Public Company Limited | BUY | 1,584 @ USD 7.62 | USD 12,070 | The ETF bought 1584 new shares of NVAX (Hana Microelectronics Public Company Limited). The shares were bought for an average price of 7.62 compared to the previous average buy price of 6.53355. This is 16.6% higher than average price of previous purchases of NVAX. |
| ASTH - Astrana Health Inc | BUY | 422 @ USD 28.18 | USD 11,892 | The ETF bought 422 new shares of ASTH (Astrana Health Inc). The shares were bought for an average price of 28.18 compared to the previous average buy price of 26.4973. This is 6.4% higher than average price of previous purchases of ASTH. |
| CERT - Certara Inc | BUY | 1,224 @ USD 9.49 | USD 11,616 | The ETF bought 1224 new shares of CERT (Certara Inc). The shares were bought for an average price of 9.49 compared to the previous average buy price of 10.3575. This is -8.4% lower than average price of previous purchases of CERT. |
| EVT.DE - Evotec SE | BUY | 1,578 @ EUR 7.35269 | EUR 11,603 | The ETF bought 1578 new shares of EVT.DE (Evotec SE). The shares were bought for an average price of 7.35269 compared to the previous average buy price of 6.56011. This is 12.1% higher than average price of previous purchases of EVT.DE. |
| ONT.L - Oxford Nanopore Technologies Ltd | BUY | 6,030 @ GBP 1.92083 | GBP 11,583 | The ETF bought 6030 new shares of ONT.L (Oxford Nanopore Technologies Ltd). The shares were bought for an average price of 1.92083 compared to the previous average buy price of 1.72755. This is 11.2% higher than average price of previous purchases of ONT.L. |
| 4587.T - PeptiDream Inc. | BUY | 1,000 @ JPY 11.092 | JPY 11,092 | The ETF bought 1000 new shares of 4587.T (PeptiDream Inc.). The shares were bought for an average price of 11.092 compared to the previous average buy price of 11.0208. This is 0.6% higher than average price of previous purchases of 4587.T. |
| 039200.KQ - Oscotec Inc. | BUY | 350 @ KRW 31.5298 | KRW 11,035 | The ETF bought 350 new shares of 039200.KQ (Oscotec Inc.). The shares were bought for an average price of 31.5298 compared to the previous average buy price of 21.1692. This is 48.9% higher than average price of previous purchases of 039200.KQ. |
| ANAB - AnaptysBio Inc | BUY | 226 @ USD 45.21 | USD 10,217 | The ETF bought 226 new shares of ANAB (AnaptysBio Inc). The shares were bought for an average price of 45.21 compared to the previous average buy price of 24.2251. This is 86.6% higher than average price of previous purchases of ANAB. |
| CDNA - Caredx Inc | BUY | 540 @ USD 18.9 | USD 10,206 | The ETF bought 540 new shares of CDNA (Caredx Inc). The shares were bought for an average price of 18.9 compared to the previous average buy price of 19.2054. This is -1.6% lower than average price of previous purchases of CDNA. |
| IART - Integra LifeSciences Holdings | BUY | 764 @ USD 13.15 | USD 10,047 | The ETF bought 764 new shares of IART (Integra LifeSciences Holdings). The shares were bought for an average price of 13.15 compared to the previous average buy price of 15.8779. This is -17.2% lower than average price of previous purchases of IART. |
| ABCL - Abcellera Biologics Inc | BUY | 2,428 @ USD 4.13 | USD 10,028 | The ETF bought 2428 new shares of ABCL (Abcellera Biologics Inc). The shares were bought for an average price of 4.13 compared to the previous average buy price of 3.60785. This is 14.5% higher than average price of previous purchases of ABCL. |
| AMLX - Amylyx Pharmaceuticals Inc | BUY | 776 @ USD 11.99 | USD 9,304 | The ETF bought 776 new shares of AMLX (Amylyx Pharmaceuticals Inc). The shares were bought for an average price of 11.99 compared to the previous average buy price of 13.2037. This is -9.2% lower than average price of previous purchases of AMLX. |
| ARVN - Arvinas Inc | BUY | 742 @ USD 12.41 | USD 9,208 | The ETF bought 742 new shares of ARVN (Arvinas Inc). The shares were bought for an average price of 12.41 compared to the previous average buy price of 11.3713. This is 9.1% higher than average price of previous purchases of ARVN. |
| 302440.KS - SK BIOSCIENCE LTD | BUY | 274 @ KRW 32.567 | KRW 8,923 | The ETF bought 274 new shares of 302440.KS (SK BIOSCIENCE LTD). The shares were bought for an average price of 32.567 compared to the previous average buy price of 36.1184. This is -9.8% lower than average price of previous purchases of 302440.KS. |
| JANX - Janux Therapeutics Inc | BUY | 604 @ USD 13.98 | USD 8,444 | The ETF bought 604 new shares of JANX (Janux Therapeutics Inc). The shares were bought for an average price of 13.98 compared to the previous average buy price of 24.6116. This is -43.2% lower than average price of previous purchases of JANX. |
| EUZ.DE - Eckert & Ziegler SE | BUY | 454 @ EUR 18.4577 | EUR 8,380 | The ETF bought 454 new shares of EUZ.DE (Eckert & Ziegler SE). The shares were bought for an average price of 18.4577 compared to the previous average buy price of 18.6179. This is -0.9% lower than average price of previous purchases of EUZ.DE. |
| KURA - Kura Oncology Inc | BUY | 826 @ USD 9.97 | USD 8,235 | The ETF bought 826 new shares of KURA (Kura Oncology Inc). The shares were bought for an average price of 9.97 compared to the previous average buy price of 10.609. This is -6.0% lower than average price of previous purchases of KURA. |
| IOVA - Iovance Biotherapeutics Inc | BUY | 2,928 @ USD 2.77 | USD 8,111 | The ETF bought 2928 new shares of IOVA (Iovance Biotherapeutics Inc). The shares were bought for an average price of 2.77 compared to the previous average buy price of 2.41741. This is 14.6% higher than average price of previous purchases of IOVA. |
| 007390.KQ - NatureCell Co.,Ltd. | BUY | 554 @ KRW 14.2437 | KRW 7,891 | The ETF bought 554 new shares of 007390.KQ (NatureCell Co.,Ltd.). The shares were bought for an average price of 14.2437 compared to the previous average buy price of 21.3643. This is -33.3% lower than average price of previous purchases of 007390.KQ. |
| DAWN - Day One Biopharmaceuticals Inc | BUY | 806 @ USD 9.61 | USD 7,746 | The ETF bought 806 new shares of DAWN (Day One Biopharmaceuticals Inc). The shares were bought for an average price of 9.61 compared to the previous average buy price of 8.51758. This is 12.8% higher than average price of previous purchases of DAWN. |
| CTKB - Cytek Biosciences Inc | BUY | 1,388 @ USD 5.5 | USD 7,634 | The ETF bought 1388 new shares of CTKB (Cytek Biosciences Inc). The shares were bought for an average price of 5.5 compared to the previous average buy price of 5.6893. This is -3.3% lower than average price of previous purchases of CTKB. |
| EMBC - Embecta Corp | BUY | 608 @ USD 12.5 | USD 7,600 | The ETF bought 608 new shares of EMBC (Embecta Corp). The shares were bought for an average price of 12.5 compared to the previous average buy price of 12.8193. This is -2.5% lower than average price of previous purchases of EMBC. |
| 328130.KQ - Lunit Inc. | BUY | 282 @ KRW 26.7243 | KRW 7,536 | The ETF bought 282 new shares of 328130.KQ (Lunit Inc.). The shares were bought for an average price of 26.7243 compared to the previous average buy price of 36.1354. This is -26.0% lower than average price of previous purchases of 328130.KQ. |
| RGNX - Regenxbio Inc | BUY | 470 @ USD 15.24 | USD 7,163 | The ETF bought 470 new shares of RGNX (Regenxbio Inc). The shares were bought for an average price of 15.24 compared to the previous average buy price of 8.80724. This is 73.0% higher than average price of previous purchases of RGNX. |
| VLA.PA - Valneva SE | BUY | 1,448 @ EUR 4.92128 | EUR 7,126 | The ETF bought 1448 new shares of VLA.PA (Valneva SE). The shares were bought for an average price of 4.92128 compared to the previous average buy price of 2.93259. This is 67.8% higher than average price of previous purchases of VLA.PA. |
| RO.SW - | BUY | 16 @ CHF 434.264 | CHF 6,948 | The ETF bought 16 new shares of RO.SW (). The shares were bought for an average price of 434.264 compared to the previous average buy price of 371.765. This is 16.8% higher than average price of previous purchases of RO.SW. |
| PACB - Pacific Biosciences of California | BUY | 3,190 @ USD 2.13 | USD 6,795 | The ETF bought 3190 new shares of PACB (Pacific Biosciences of California). The shares were bought for an average price of 2.13 compared to the previous average buy price of 1.38552. This is 53.7% higher than average price of previous purchases of PACB. |
| VIR - Vir Biotechnology Inc | BUY | 1,074 @ USD 6.16 | USD 6,616 | The ETF bought 1074 new shares of VIR (Vir Biotechnology Inc). The shares were bought for an average price of 6.16 compared to the previous average buy price of 7.17028. This is -14.1% lower than average price of previous purchases of VIR. |
| VIR - Vidrala S.A | BUY | 1,074 @ USD 6.16 | USD 6,616 | The ETF bought 1074 new shares of VIR (Vidrala S.A). The shares were bought for an average price of 6.16 compared to the previous average buy price of 7.17028. This is -14.1% lower than average price of previous purchases of VIR. |
| MYGN - Myriad Genetics Inc | BUY | 964 @ USD 6.63 | USD 6,391 | The ETF bought 964 new shares of MYGN (Myriad Genetics Inc). The shares were bought for an average price of 6.63 compared to the previous average buy price of 8.54619. This is -22.4% lower than average price of previous purchases of MYGN. |
| 096530.KQ - Seegene, Inc. | BUY | 382 @ KRW 16.2835 | KRW 6,220 | The ETF bought 382 new shares of 096530.KQ (Seegene, Inc.). The shares were bought for an average price of 16.2835 compared to the previous average buy price of 17.5828. This is -7.4% lower than average price of previous purchases of 096530.KQ. |
| 7575.T - Japan Lifeline Co., Ltd. | BUY | 600 @ JPY 10.358 | JPY 6,215 | The ETF bought 600 new shares of 7575.T (Japan Lifeline Co., Ltd.). The shares were bought for an average price of 10.358 compared to the previous average buy price of 10.1362. This is 2.2% higher than average price of previous purchases of 7575.T. |
| XVIVO.ST - | BUY | 260 @ SEK 20.6218 | SEK 5,362 | The ETF bought 260 new shares of XVIVO.ST (). The shares were bought for an average price of 20.6218 compared to the previous average buy price of 39.4797. This is -47.8% lower than average price of previous purchases of XVIVO.ST. |
| IBRX - Immunitybio Inc | BUY | 2,436 @ USD 2.2 | USD 5,359 | The ETF bought 2436 new shares of IBRX (Immunitybio Inc). The shares were bought for an average price of 2.2 compared to the previous average buy price of 2.80572. This is -21.6% lower than average price of previous purchases of IBRX. |
| MRVI - Maravai Lifesciences Holdings Inc | BUY | 1,386 @ USD 3.86 | USD 5,350 | The ETF bought 1386 new shares of MRVI (Maravai Lifesciences Holdings Inc). The shares were bought for an average price of 3.86 compared to the previous average buy price of 2.98184. This is 29.5% higher than average price of previous purchases of MRVI. |
| VNDA - Vanda Pharmaceuticals Inc | BUY | 598 @ USD 8.53999 | USD 5,107 | The ETF bought 598 new shares of VNDA (Vanda Pharmaceuticals Inc). The shares were bought for an average price of 8.53999 compared to the previous average buy price of 4.89461. This is 74.5% higher than average price of previous purchases of VNDA. |
| 1877.HK - SHANGHAI JUNSHI BIOSCIENCES LTD H | BUY | 1,600 @ HKD 3.0849 | HKD 4,936 | The ETF bought 1600 new shares of 1877.HK (SHANGHAI JUNSHI BIOSCIENCES LTD H). The shares were bought for an average price of 3.0849 compared to the previous average buy price of 2.5435. This is 21.3% higher than average price of previous purchases of 1877.HK. |
| LAB - Standard Biotools Inc | BUY | 3,684 @ USD 1.28 | USD 4,716 | The ETF bought 3684 new shares of LAB (Standard Biotools Inc). The shares were bought for an average price of 1.28 compared to the previous average buy price of 1.36709. This is -6.4% lower than average price of previous purchases of LAB. |
| EVH - Evolent Health Inc | BUY | 1,128 @ USD 4.15 | USD 4,681 | The ETF bought 1128 new shares of EVH (Evolent Health Inc). The shares were bought for an average price of 4.15 compared to the previous average buy price of 9.2746. This is -55.3% lower than average price of previous purchases of EVH. |
| 4549.T - Eiken Chemical Co., Ltd. | BUY | 200 @ JPY 15.687 | JPY 3,137 | The ETF bought 200 new shares of 4549.T (Eiken Chemical Co., Ltd.). The shares were bought for an average price of 15.687 compared to the previous average buy price of 13.7463. This is 14.1% higher than average price of previous purchases of 4549.T. |
| SLP - Sylvania Platinum Limited | BUY | 162 @ USD 18.99 | USD 3,076 | The ETF bought 162 new shares of SLP (Sylvania Platinum Limited). The shares were bought for an average price of 18.99 compared to the previous average buy price of 25.9621. This is -26.9% lower than average price of previous purchases of SLP. |
| 4974.T - Takara Bio Inc. | BUY | 400 @ JPY 5.23326 | JPY 2,093 | The ETF bought 400 new shares of 4974.T (Takara Bio Inc.). The shares were bought for an average price of 5.23326 compared to the previous average buy price of 5.70398. This is -8.3% lower than average price of previous purchases of 4974.T. |
| ARCT - Arcturus Therapeutics Holdings Inc | BUY | 242 @ USD 6.83999 | USD 1,655 | The ETF bought 242 new shares of ARCT (Arcturus Therapeutics Holdings Inc). The shares were bought for an average price of 6.83999 compared to the previous average buy price of 12.3242. This is -44.5% lower than average price of previous purchases of ARCT. |
| - - | HOLD | 0 @ USD 0 | USD 0 | The current share valuation price of - based on adjusted close was USD 0. The average price that - shares were previous bought at was USD 0.00279608. The current market price is -100.0% lower than average price they were purchased at. USD 0 compared to the previous valuation of however if the holding was sold on 2026-01-07 this would crystalise an overall loss. |
| 182400.KQ - NKMAX LTD | HOLD | 0 @ KRW 3.98064 | KRW 0 | |